ConductScience.org, home

Trial · NCT07905638

Comparative Study of the Genomic Characteristics of Uropathogenic Escherichia Coli According to the Severity of Community-Acquired Urinary Tract Infections in Guadeloupe (COLIGENURI)

NCT07905638, Not yet recruiting, Centre Hospitalier Universitaire de la Guadeloupe

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Comparative Study of the Genomic Characteristics of Uropathogenic Escherichia Coli According to the Severity of Community-Acquired Urinary Tract Infections in Guadeloupe (COLIGENURI). Trials, record NCT07905638. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07905638

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Comparative Study of the Genomic Characteristics of Uropathogenic Escherichia Coli According to the Severity of Community-Acquired Urinary Tract Infections in Guadeloupe (COLIGENURI)
NCT number
NCT07905638
Status
Not yet recruiting
Enrollment
210 participants, estimated
Lead sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Conditions
Urinary Tract Infections
Interventions
Whole-genome sequencing (WGS) of E. coli isolates (applies to all 3 groups)
First posted
2026-10-29
Last updated
2026-10-29

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDifferential frequency of virulence genes or gene clusters in E. coli isolates, compared according to the severity level of community-acquired urinary tract infectionAt the end of the 12-month inclusion periodpan-genome-wide association study
SecondaryFrequency and diversity of virulence and antibiotic resistance genes according to UTI severity (association between combined virulence/resistance profiles and severity levels)At the end of the 12-month inclusion period (genomic analysis of all stored isolates, performed after sequencing)]Genes identified from whole-genome sequences using VFDB and ResFinder.
SecondaryClonal characteristics of the uropathogenic E. coli isolates and their distribution according to severity of the cases.: At the end of the 12-month inclusion period (genomic analysis of all stored isolates, performed after sequencing)sequence types by MLST, phylogroups)
SecondaryGenetic proximity between clinical and environmental E. coli isolates from GuadeloupeAt the end of the 12-month inclusion period (genomic analysis of all stored isolates, performed after sequencing)by MLST/cgMLST typing and core-genome SNP phylogeny

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07905638

GET https://conductscience.org/api/trials/v1/NCT07905638/registered